Related Experiment Video
Updated: Aug 6, 2026

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
Published on: February 7, 2025
Violations of the breast milk substitutes act-2013 and its rules - 2017 in Bangladesh
S K Roy1,2, Khurshid Jahan3, Saria Tasnim4,5
1Bangladesh Breastfeeding Foundation (BBF), Room # 197-200, Institute of Public Health (IPH), Mohakhali, Dhaka, Bangladesh. skroy1950@gmail.com.
Insights
Violations of Bangladesh's Breast-milk Substitute (BMS) Act are widespread, with retailers and health professionals promoting BMS products unethically. Urgent enforcement is needed to protect infant feeding practices and reduce child mortality.
Area of Science:
- Public Health
- Nutrition Policy
- Child Health
Background:
- Inadequate breastfeeding practices contribute to significant infant mortality and morbidity globally.
- Bangladesh faces challenges with exclusive breastfeeding rates, necessitating regulatory measures.
- The Breast-milk Substitute (BMS) Act of 2013 and its 2017 Rules were enacted to regulate BMS marketing.
Purpose of the Study:
- To assess violations of the BMS Act, 2013, and Rules, 2017 in Bangladesh.
- To identify the types, actors, and settings of BMS Act violations.
- To raise awareness about the BMS Act among stakeholders and the public.
Main Methods:
- A cross-sectional survey was conducted across eight divisions of Bangladesh.
- Data collection involved retail outlets, pharmacies, baby-friendly hospitals, health professionals, and mothers.
- Methods included structured interviews, direct observations, and document reviews using standardized protocols.
Main Results:
- All surveyed retail outlets sold unregistered BMS products with promotional materials and health claims.
- A significant percentage of doctors and nurses promoted BMS without medical indication.
- Health facilities reported financial incentives from BMS manufacturers, and manufacturers established unauthorized breastfeeding corners.
Conclusions:
- Extensive violations of the BMS Act and Rules were identified, indicating unethical promotion and distribution of BMS.
- Health professionals in baby-friendly hospitals were implicated in these breaches, undermining breastfeeding.
- Urgent monitoring and enforcement are crucial to protect infant health and uphold national regulations.
Background:
Inadequate breastfeeding practices increase the risk of mortality and morbidity among infants and young children. Recent global estimates suggest that inadequate breastfeeding is responsible for approximately 16% of child deaths worldwide each year, highlighting the ongoing need to strengthen support systems to improve infant and young child feeding practice in Bangladesh, 55% of infants under six months of age are exclusively breastfed. To improve breastfeeding rates and reduce infant mortality, the Government of Bangladesh enacted the Breast-milk Substitute (BMS) Act, 2013, and its Rules in 2017 to regulate the marketing of breast-milk substitutes.
Objectives:
The study aimed to assess violations of the BMS Act, 2013, and Rules, 2017, focusing on the types, actors, and settings of such violations, while also raising awareness of the Act among key stakeholders and the public.
Method:
We carried out a cross-sectional survey among 818 retail outlets and pharmacies; 969 baby-friendly hospitals; 969 doctors, nurses, and other health professionals; and 315 mothers with children aged 0-24 months across eight divisions of Bangladesh from August 2016 to December 2019. Data were collected through structured interviews, direct observations, and document reviews using a modified International Baby Food Action Network-International Code Documentation Centre (IBFAN-ICDC) protocol and the BFHI Hospital External Assessment Tool.
Results:
All retail outlets surveyed (n = 818) sold unregistered BMS products, and all displayed promotional materials. These retail outlets also sold BMS products labeled with health and nutrition claims. In hospitals, 25.5% of doctors (n = 247) and 21.3% of nurses and other health professionals (n = 206) promoted BMS without medical indication. Additionally, 32.0% of health facilities (n = 300) reported providing financial incentives to health professionals to participate in events sponsored by BMS manufacturers. Furthermore, BMS manufacturers violated the BMS Act, 2013 by establishing breastfeeding corners in 164 hospitals (17.5%).
Conclusion:
This study identified extensive violations of the BMS Act 2013 and its Rules 2017 in Bangladesh, revealing unethical promotion and distribution of BMS. Health professionals in BFHI-trained hospitals played a significant role in these breaches, contributing to the erosion of breastfeeding practices. Urgent monitoring and enforcement are needed to protect infant health and uphold national regulations.
Related Concept Videos
Clinically Relevant Drug Product Specifications: Methods of Establishment
Good Manufacturing Practices
Drug Products: Biologics, Biosimilars and Interchangeables
Development of Human Microbiota
Investigation of Disease Outbreaks
Parental Care

